TY  - GEN
AU  - Bernhard,Jürg
AU  - Luo,Weixiu
AU  - Ribi,Karin
AU  - Colleoni,Marco
AU  - Burstein,Harold J
AU  - Tondini,Carlo
AU  - Pinotti,Graziella
AU  - Spazzapan,Simon
AU  - Ruhstaller,Thomas
AU  - Puglisi,Fabio
AU  - Pavesi,Lorenzo
AU  - Parmar,Vani
AU  - Regan,Meredith M
AU  - Pagani,Olivia
AU  - Fleming,Gini F
AU  - Francis,Prudence A
AU  - Price,Karen N
AU  - Coates,Alan S
AU  - Gelber,Richard D
AU  - Goldhirsch,Aron
AU  - Walley,Barbara A
TI  - Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials
SN  - 1474-5488
PY  - 2015///0928
KW  - Administration, Oral
KW  - Adult
KW  - Antineoplastic Agents, Hormonal
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Early Detection of Cancer
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - pathology
KW  - Neoplasm Staging
KW  - Ovary
KW  - drug effects
KW  - Premenopause
KW  - physiology
KW  - Quality of Life
KW  - Risk Assessment
KW  - Self Report
KW  - Survival Analysis
KW  - Tamoxifen
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(15)00049-2
ER  -